Drabmedica - Company finances
|
EUR
|
2019
From: 2019-07-31
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 55,578 | 186,168 | 348,270 | 318,077 | 353,839 | 435,849 | 484,845 |
| Profit before tax | - | - | - | - | - | - | - |
| Net profit | 11,733 | 35,729 | 18,333 | 462 | 22,818 | 14,129 | 241 |
| Equity | 13,233 | 51,962 | 70,296 | 70,758 | 93,576 | 107,704 | 106,782 |
| Liabilities | 50,683 | 56,706 | 69,417 | 44,902 | 16,820 | 27,141 | 79,662 |
| Non-current assets | 12,513 | 13,118 | 12,773 | 11,607 | 4,981 | 2,598 | 1,582 |
| Current assets | 51,013 | 94,134 | 126,602 | 103,719 | 105,293 | 132,167 | 184,495 |
| Total assets | 63,526 | 107,252 | 139,375 | 115,326 | 110,274 | 134,765 | 186,077 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 32,785 | 41,965 | 32,436 |
| Social insurance contributions | - | - | - | - | - | 4,026 | - |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +235.0% | +87.1% | -8.7% | +11.2% | +23.2% | +11.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 18.5% | 33.3% | 13.2% | 0.4% | 20.7% | 10.5% | 0.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 88.7% | 68.8% | 26.1% | 0.7% | 24.4% | 13.1% | 0.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 21.1% | 19.2% | 5.3% | 0.1% | 6.4% | 3.2% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.8 | 1.1 | 1.0 | 0.6 | 0.2 | 0.3 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 23,158 | 69,812 | 116,090 | 106,026 | 117,946 | 141,358 | 161,615 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Drabmedica - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-12-16 | 2025-12-21 | 3.36 |
| 2025-11-18 | 2025-11-26 | 3.36 |
| 2025-10-23 | 2025-10-27 | 3.36 |
| 2025-07-16 | 2025-07-23 | 1381.79 |
Drabmedica - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-29 | 2026-04-15 | 0.28 |
| 2026-01-20 | 2026-01-20 | 0.76 |
| 2026-01-09 | 2026-01-19 | 158.33 |
| 2025-11-30 | 2025-11-30 | 26.16 |
| 2025-08-06 | 2025-08-07 | 57.28 |
| 2025-07-08 | 2025-07-20 | 1419.33 |
| 2024-11-28 | 2024-12-05 | 12.96 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Drabmedica, UAB (code 305220640) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company increased revenue to €484.8K, up 11.2% year on year and 37.0% over two years from €353.8K in 2023. Despite the stronger sales trajectory, profitability weakened markedly: net profit fell to €241 in 2025 from €14.1K in 2024 and €22.8K in 2023, leaving a profit margin of 0.1%. The company’s balance sheet expanded to €186.1K in total assets, supported by €106.8K in equity and €79.7K in liabilities. Equity represented 57.4% of assets, while debt-to-equity stood at 0.75. Short-term assets dominated the asset base at €184.5K, compared with €1.6K in long-term assets. Key efficiency indicators were modest: return on equity was 0.2%, return on assets 0.1%, and asset turnover 2.61x. Revenue per employee was €161.6K, indicating solid sales productivity relative to staffing.